Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1260321000001119 | Ravulizumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1260341000001112 | Ravulizumab (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ravulizumab | Is a | Monoclonal antibody | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ravulizumab 300mg/30ml solution for infusion vials | Has specific active ingredient | False | Ravulizumab | Inferred relationship | Existential restriction modifier | |
| Ultomiris 300mg/30ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial | Has specific active ingredient | False | Ravulizumab | Inferred relationship | Existential restriction modifier | |
| Ultomiris 300mg/30ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) | Has specific active ingredient | False | Ravulizumab | Inferred relationship | Existential restriction modifier | |
| Ravulizumab 300mg/30ml solution for infusion vials 1 vial | Has specific active ingredient | False | Ravulizumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR